A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy

Mathematical Biosciences

Volumn 164, Issue 1, 2000, Pages 17-38

  Jackson, Trachette L ^a   Byrne, Helen M ^b  

^a DUKE UNIVERSITY   (United States)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Chemotherapy; Mathematical model; Vascular tumors

Indexed keywords

CEPHALOSPORIN; DOXORUBICIN; HYBRID PROTEIN;

ARTICLE; CANCER CHEMOTHERAPY; CARCINOGENESIS; CELL DEATH; CELL DENSITY; CELL PROLIFERATION; DATA ANALYSIS; MATHEMATICAL MODEL; SOLID TUMOR; TUMOR CELL CULTURE; VASCULAR TUMOR;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DEATH; CELL DIVISION; COMPUTER SIMULATION; DRUG RESISTANCE, NEOPLASM; HUMANS; MICE; MICE, NUDE; MODELS, BIOLOGICAL; VASCULAR NEOPLASMS;

EID: 0034104342     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-5564(99)00062-0     Document Type: Article

References (38)

1. Adam J.A. A mathematical model of tumor growth. ii: Effects of geometry and spatial uniformity on stability. Math. Biosci. 86:1987;183.
2. Adam J.A. A mathematical model of tumor growth iii: Comparison with experiment. Math. Biosci. 86:1987;213.
3. Adam J.A., Maggelakis S.A. Diffusion regulated growth characterisitcs of a spherical prevascular carcinoma. Bull. Math. Biol. 52:1990;549.
4. Byrne H.M., Chaplain M.A.J. Growth of non-necrotic tumors in the presence and absence of inhibitiors. Math. Biosci. 130:1995;151.
5. Byrne H.M., Chaplain M.A.J. Growth of necrotic tumors in the presence and absence of inhibitors. Math. Biosci. 135:1996;187.
6. Greenspan H.P. Models for the growth of a solid tumor by diffusion. Stud. Appl. Math. 52:1972;317.
7. Greenspan H.P. On the growth and stability of cell cultures and solid tumors. J. Theor. Biol. 56:1976;229.
8. Maggelakis S.A., Adam J.A. Mathematical model of prevascular growth of a spherical carcinoma. Math. Comput. Modelling. 13:1990;23.
9. Ward J.P., King J.R. Mathematical modeling of avascular-tumor growth. IMA J. Math. Appl. Med. Biol. 14:1997;39.
10. Folkman J., Hochberg M. Self-regulation of growth in three-dimensions. J. Exp. Med. 138:1973;743.
11. Kunz-Schughart L.A., Kreutz M., Kneuchel R. Multicellular spheroids: a three- dimensional in vitro culture system to study tumor biology. Int. J. Eng. Path. 79:1979;1.
12. Sutherland R.M., Durand R.E. Growth and cellular characteristics of multicell spheroids. Recent Results Cancer Res. 95:1994;510.
13. Marusic M., Bajzer Z., Vuk-Pavlovic S., Freyer J.P. Tumor growth in vivo and as multicellular spheroids compared by mathematical models. Bull. Math. Biol. 56:1994;617.
14. P.D. Senter, J.D. Murray, Development and validation of a mathematical model to describe anti-cancer prodrug activation by antibody-enzyme conjugates, J. Theor. Med., in press.
15. Jackson T.L., Lubkin S.R., Murray J.D. Theoretical analysis of conjugate localization in two-step cancer chemotherapy. J. Math. Bio. 39:1999;353.
16. Gerlowski L.E., Jain R.K. Microvascular permeability of normal and neoplastic tissues. Microvas. Res. 31:1986;288.
17. Jain R.K. Barriers to drug delivery in solid tumors. Sci. Am. 271:1994;58.
18. Siemers N.O., Kerr D.E., Yarnold S., Stebbins M., Vrudgyka V.M., Hellstrom I., Hellstrom K.E., Senter P.D. L49-sfv-. β -lactamase a single chain anti-p97 antibody fusion protein Bioconjugate Chem. 8:1997;510.
19. Crank J. Free and moving boundary problems. OUP. 1988.
20. Birkhead B.G., Rankin E.M., Gallivan S., Dones L., Rubens R.D. A mathematical model of the development of drug resistance to cancer chemotherapy. Eur. J. Cancer Clin. Oncol. 23:1987;1421.
21. Goldie J.H., Coldman A.J. A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat. Rep. 63:1971;1727.
22. Crowther D. A rational approach to the chemotherapy of human malignant disease - ii. Rit. Med. J. 4:1974;216.
23. Bagshawe K.D., Begent R.H.J. First clinical experience with ADEPT. Adv. Drug Delivery Rev. 22:1996;365.
24. Kerr D.E., Schreiber G.J., Vrudhula V.M., Svensson H.P., Hellstrom K.E., Senter P.D. Regressions and cures of melanoma xenografts following treatment with monoclonal antibody. β -lactamase conjugates in combination with anticancer prodrugs Cancer Res. 55:1995;3558.
25. Agur Z., Arnon R., Schechter B. Reduction of cytotoxicity to normal tissues by new regimens of cell cycle phase specific drugs. Math. Biosci. 92:1988;1.
26. Byrne H.M., Chaplain M.A.J. Necrosis and apoptosis: distinct cell loss mechanisms in a mathematical model of avascular tumor growth. J. Theor. Med. 1:1998;223.
27. Folkman J. Fighting cancer by attacking its blood supply. Sci. Am. 1996;150.
28. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86:1996;353.
29. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., Flynn E., Birkhead J.R., Folkman J. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell. 88:1997;277.
30. Byrne H.M., Gourley S.A. The role of growth factors in avascular tumour growth. Math. Comput. Modeling. 26:1997;83.
31. Byrne H.M., Chaplain M.A.J. Free boundary value problems associated with the growth and development of multicellular spheroids. Eur. J. Appl. Math. 8:1997;639.
32. Byrne H.M. A weakly nonlinear analysis of a model of avascular solid tumour growth. J. Math. Bio. 39:1997;59.
33. Baxter L.T., Yuan F., Jain R.K. Pharamacokinetic analysis of the perivascular distribution of bifunctional antiboies and haptens: comparison with experimental data. Cancer Res. 52:1992;5838.
34. Nugent L.J., Jain R.K. Extravascular diffusion in normal and neoplastic tissues. Cancer Res. 44:1984;238.
35. Dordal M.S., Winter J.N., Atkinson A.J. Kinetic analysis of p-glycoprotein-mediated doxorubicin efflux. J. Pharmacol. Exp. Ther. 263:1992;762.
36. Greenblatt D.J., Koch-Weser J. Drug therapy: clinical pharmacokinetics. NE J. Med. 293:1975;702.
37. Jain R.K. Transport of macromolecules across tumor vasculature. Cancer Metastasis Rev. 6:1987;559.
38. Robert J., Illiadia A., Hoerniand B., Cano J., Durand M., Lagarde C. Pharamacokinetics of adrianmycin in patients with breast cancer: correlation between pharmacokinetic parameters and clinical short-term respons. Eur. J. Cancer Clin. Oncol. 18:1982;739.